Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies
Yi Wang, Qiang Xie, Huidan Tan, et al.
Pharmacological Research (2021) Vol. 173, pp. 105702-105702
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 95
Regulated cell death in glioma: promising targets for natural small-molecule compounds
Mingyu Han, Sui Li, Huali Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 19
An updated patent review of BRD4 degraders
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 7
Proteomic characterization of post-translational modifications in drug discovery
Linhui Zhai, Kai‐Feng Chen, Bingbing Hao, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3112-3129
Open Access | Times Cited: 23
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
Yin-Ru Li, Fangfang Liu, Wenbo Liu, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115070-115070
Closed Access | Times Cited: 19
Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma
Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 4
Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy
Xuetao Chen, Wenjing Kang, Tingting Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Strategies to Mitigate Cisplatin-Induced Ototoxicity: A Literature Review of Protective Agents, Mechanisms, and Clinical Gaps
Alexandru Orasan, M. M. Negru, A. Morgovan, et al.
Audiology Research (2025) Vol. 15, Iss. 2, pp. 22-22
Open Access
Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review
Laertty Garcia de Sousa Cabral, Isabela Mancini Martins, Ellen Paim de Abreu Paulo, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 621-621
Open Access
Chemoinformatic Characterization of Synthetic Screening Libraries Focused on Epigenetic Targets
E. Alexis Flores‐Padilla, K. Eurídice Juárez‐Mercado, J. Jesús Naveja, et al.
Molecular Informatics (2021) Vol. 41, Iss. 6
Open Access | Times Cited: 25
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer
Parama Dey, Alexander Wang, Yvonne Ziegler, et al.
Endocrinology (2022) Vol. 163, Iss. 12
Open Access | Times Cited: 15
Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology
Nazanin Zohourian, Erin Coll, Muiread Dever, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2677-2677
Open Access | Times Cited: 2
Novel Histone Acetyltransferase (HAT) Inhibitors for Treating Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 8, pp. 1198-1199
Open Access | Times Cited: 15
Hydroxytyrosol decreases EDNRA expression through epigenetic modification in colorectal cancer cells
Andrea del Saz‐Lara, Hatim Boughanem, María‐Carmen López de las Hazas, et al.
Pharmacological Research (2022) Vol. 187, pp. 106612-106612
Open Access | Times Cited: 10
Design, synthesis, and biological evaluation of novel dual inhibitors of heat shock protein 90/mammalian target of rapamycin (Hsp90/mTOR) against bladder cancer cells
Zhaoping Pan, Yi Chen, Haiying Pang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114674-114674
Closed Access | Times Cited: 9
Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis
Fei Xiong, Qiao Zhou, Xiaobo Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation
Palmiro Poltronieri
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 841-876
Open Access | Times Cited: 1
Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA
Qijie Ran, Dehong Xu, Qi Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
NHWD-870 protects the kidney from ischemia/reperfusion injury by upregulating the PI3K/AKT signaling pathway (experimental study)
Najah R. Hadi, Saba Sahib Younis, Fadhaa Abdul Ameer Ghafil, et al.
Journal of Medicine and Life (2023) Vol. 16, Iss. 6, pp. 925-931
Open Access | Times Cited: 3
Tackling the tumor microenvironment – how can complex tumor models in vitro aid oncology drug development?
Megan C. Cox, Rita Mendes, Kathleen N. Halwachs, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 7, pp. 753-768
Closed Access | Times Cited: 2
In Silico Discovery of Class IIb HDAC Inhibitors: The State of Art
Samima Khatun, Sk. Abdul Amin, Shovanlal Gayen, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 25-55
Closed Access | Times Cited: 2
Tenovin-6 exhibits inhibitory effects on the growth of Sonic Hedgehog (SHH) medulloblastoma, as evidenced by both in vitro and in vivo studies
Bohong Wang, Tao Xu, Chenjie Qiu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113075-113075
Closed Access
Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review
Mozhdeh Zamani, Farima Safari, Morvarid Siri, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access
Page 1 - Next Page

Scroll to top